BeiGene
BGNE
#907
Rank
C$30.56 B
Marketcap
$271.34
Share price
3.46%
Change (1 day)
5.23%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeiGene (BGNE)

Market cap: C$30.56 Billion

As of November 2024 BeiGene has a market cap of C$30.56 Billion. This makes BeiGene the world's 907th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeiGene from 2016 to 2024

End of year Market Cap

Year Marketcap Change
2024C$30.56 B16.27%
2023C$26.28 B-17.43%
2022C$31.83 B-9.13%
2021C$35.03 B14.34%
2020C$30.64 B128.03%
2019C$13.43 B18.35%
2018C$11.35 B102.91%
2017C$5.59 B245.63%
2016C$1.61 B

End of Day market cap according to different sources

On Nov 20th, 2024 the market cap of BeiGene was reported to be:

C$30.28 Billion
by Yahoo Finance info icon info icon
C$30.28 Billion
by CompaniesMarketCap info icon info icon
C$28.92 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
C$29.19 M-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.48 B-95.14%๐Ÿ‡บ๐Ÿ‡ธ USA